Physician profile
Herbert Dardik
NPI 1043250434
$6,904.29
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $6,904.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $6,000.00 | 2019 | |
| Medtronic Vascular, INC. | $418.62 | 2019 | |
| Endologix LLC | $261.35 | 2019 | |
| W. L. Gore & Associates, INC. | $113.84 | 2019 | |
| Silk Road Medical, INC. | $48.42 | 2019 | |
| Boston Scientific Corporation | $26.81 | 2019 | |
| Integra Lifesciences Corporation | $24.07 | 2019 | |
| Aroa Biosurgery Incorporated | $11.18 | 2019 |
Research and ownership
$4,250.56 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herbert Dardik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.